Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Conditions:   Breast Cancer Female;   HER2-positive Breast Cancer;   Hormone Receptor Positive Malignant Neoplasm of Breast;   Metastatic Breast Cancer;   Breast Diseases;   Hormone Receptor Positive Tumor Interventions:   Drug: Pyrotinib;   Drug: Trastuzumab;   Drug: Aromatase Inhibitors Sponsor:   Fuzhou General Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials